Last reviewed · How we verify
NCT07146178
Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS
NA trial testing Enhanced Recovery After Surgery in Gynecologic Surgery in 200 participants. Not yet recruiting.
1 October 2025
Quick facts
| Lead sponsor | Wonju Severance Christian Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 September 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 October 2026 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Enhanced Recovery After Surgery — full drug profile →
- Usual Care
Conditions studied
- Gynecologic Surgery — all drugs for Gynecologic Surgery →
- General Anesthesia — all drugs for General Anesthesia →
Sponsor
Wonju Severance Christian Hospital
Who can join
Adults 20 to 70, female only, with Gynecologic Surgery or General Anesthesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments? Researchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery. Participants will: * Receive ERAS protocol during the hospitalization * Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7 * Visit the hospital at one week and one month after discharge * Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07146178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Enhanced Recovery After Surgery
Trials testing the same drug.
- NCT07116564 — Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries · Phase 4 · recruiting
- NCT05448846 — Exercise Program for Colorectal Older Patients · NA · active not recruiting
- NCT04977362 — Interdisciplinary Perioperative Care in Minimally-invasive Heart Valve Surgery · NA · completed
- NCT04505111 — Prehabilitation Plus ERAS vs ERAS in Gynecological Surgery · NA · withdrawn
Other recruiting trials for Gynecologic Surgery
Currently open trials in the same condition.
- NCT07114965 — Effects Of Quadratus Lumborum Type 1 Block And Transversalis Facial Plane Block On Acute Pain In Gynecological Surgery · active not recruiting
- NCT05526534 — A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms · NA · recruiting
- NCT05071976 — A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery · NA · active not recruiting
Other Wonju Severance Christian Hospital trials
Trials by the same sponsor.
- NCT07012499 — QOL and Mental Health Using APD With Remote Monitoring System · NA · enrolling by invitation
- NCT06675396 — Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients · not yet recruiting
- NCT06540430 — Digital Based Home Care Service for Ostomy Patients · NA · not yet recruiting
- NCT07017088 — Efficacy of Leuconostoc Mesenteroides · NA · completed
- NCT06625918 — Effects of Ultraviolet B Exposure Using a Ultraviolet Skin Care Device on Vitamin D Production and Immune Response in He · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07146178 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wonju Severance Christian Hospital
- Last refreshed: 28 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07146178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing